[Home ] [Archive]   [ فارسی ]  
:: ::
:: Volume 16, Issue 1 (April 2022) ::
Qom Univ Med Sci J 2022, 16(1): 52-65 Back to browse issues page
Consumption Pattern of Black Myrobalan for Prevention and Treatment of COVID-19 and People’ Attitude Towards it in Qom, Iran: A Cross-Sectional Study
Fataneh Hashem-Dabaghian1 , Fatemeh Nojavan2 , Abolfazl Mohammadbeigi3 , Mohammad Aligol4 , Mahmood Shokuhitabar5 , Atieh-sadat Danesh * 6
1- Department of Iranian Medicine, Institute of Medical History Studies, Islamic and Complementary Medicine, Faculty of Iranian Medicine, Iran University of Medical Sciences, Tehran, Iran.
2- Department of Persian Medicine, School of Traditional Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Department of Biostatistics and Epidemiology, School of Health, Environmental Pollution Health Center, Qom University of Medical Sciences, Qom, Iran.
4- Assistant Professor, Department of Health Education and Promotion, School of Health, Qom University of Medical Sciences, Qom, Ira
5- Department of Quranic and Hadith Sciences in Health, Faculty of Health and Religion, Qom University of Medical Sciences, Qom, Iran.
6- Department of Persian Medicine, School of Traditional Medicine, Qom University of Medical Sciences, Qom, Iran. , adanesh@muq.ac.ir
Abstract:   (639 Views)
Background and Objectives: Black myrobalan drug, known as “Imam Kazem drug” in Iran, is used by most of Iranian people to prevent and treat the coronavirus disease 2019 (COVID-19). This study aims to investigate the consumption pattern of black myrobalan by people in Qom, Iran and their attitudes towards it.
Methods: In this cross-sectional study, 1077 patients referred to health centers in Qom, Iran in 2021 participated. They completed a demographic form and a researcher-made questionnaire assessing the consumption pattern of black myrobalan and people’s attitudes towards this drug. Data were analyzed in SPSS v. 20 software using chi-square test, Fisher test, Spearman correlation test, and logistic regression analysis.
Results: Out of 1018 patients who responded to the questionnaire, 660 (64.8%) were familiar with the drug and 491 (48.2%) had used the drug during the COVID-19 pandemic. Among them, 409 (83.2%) had used the drug for prevention and 166 (33.9%) for treatment of COVID-19. The attitude of participants towards this drug was positive in 515 patients (50.6%). The consumption pattern of black myrobalan was significantly correlated with occupation and attitude of people.  It was found out that 83 patients (16.9%) reported mild side effects following drug use.
Conclusion: A significant percentage of people in Qom city use black myrobalan, and have positive attitude towards it. This requires that its efficacy and side effects be investigated in clinical studies.
Keywords: Iranian medicine, Herbal medicine, Terminalia chebula Retz, Imam Kazem drug, COVID-19
Full-Text [PDF 5068 kb]   (117 Downloads)    
Type of Study: Original Article | Subject: طب سنتی
Received: 2022/04/24 | Accepted: 2022/05/15 | Published: 2022/04/30
References
1. Ang L, Song E, Lee HW, Lee MS. Herbal medicine for the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2020; 9(5):1583. [PMID] [DOI:10.3390/jcm9051583]
2. Tavakoli A, Vahdat K, Keshavarz M. Novel coronavirus disease 2019 (COVID-19): An emerging infectious disease in the 21st century. Iran South Med J. 2020; 22(6):432-50. [DOI:10.29252/ismj.22.6.432] [DOI:10.29252/ismj.22.6.432]
3. Huang J, Tao G, Liu J, Cai J, Huang Z, Chen JX. Current prevention of COVID-19: Natural products and herbal medicine. Front Pharmacol. 2020; 11:588508. [PMID] [DOI:10.3389/fphar.2020.588508]
4. Panyod S, Ho CT, Sheen LY. Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective. J Tradit Complement Med. 2020; 10(4):420-7. [PMID] [DOI:10.1016/j.jtcme.2020.05.004]
5. Liu M, Gao Y, Yuan Y, Yang K, Shi S, Tian J, et al. Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis. Integr Med Res. 2021; 10(1):100644. [PMID] [DOI:10.1016/j.imr.2020.100644]
6. Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, Liu JP. Can Chinese medicine be used for prevention of Corona Virus Disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020; 26(4):243-50. [PMID] [DOI:10.1007/s11655-020-3192-6]
7. Ang L, Lee HW, Choi JY, Zhang J, Lee MS. Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines. Integr Med Res. 2020; 9(2):100407. [PMID] [DOI:10.1016/j.imr.2020.100407]
8. Grigore A, Cord D, Tanase C, Albulescu R. Herbal medicine, a reliable support in COVID therapy. J Immunoassay Immunochem. 2020; 41(6):976-99. [PMID] [DOI:10.1080/15321819.2020.1862867]
9. Tehrani-Banihashemi SA, Asgharifard H, Haghdoost AA, Barghmadi M, Mohammadhosseini N. [The use of complementary/alternative medicine among the general population in Tehran, Iran (Persian)]. Payesh. 2008; 7(4):355-62. [Link]
10. Aghili Khorasani S. Makhzan-ol-Advieh. Tehran: Safirardeha; 2018. [Link]
11. Basha SJ, Jayasankar Reddy , Sudha Rani Y, Koshma M, Hanumanthu G, Dadakhalandar S. A review on Terminalia chebula. Int J Pharmacol Res. 2017; 7(10):187-91. [Link]
12. Deseo MA, Elkins A, Rochfort S, Kitchen B. Antioxidant activity and polyphenol composition of sugarcane molasses extract. Food Chem. 2020; 314:126180. [PMID] [DOI:10.1016/j.foodchem.2020.126180]
13. Miraj S. Pharmacological effects of Saccharum officinarum L. Der Pharm Lett. 2016; 8(13):223-5. [Link]
14. Milia E, Bullitta SM, Mastandrea G, Szotáková B, Schoubben A, Langhansová L, et al. Leaves and Fruits Preparations of Pistacia lentiscus L.: A Review on the Ethnopharmacological Uses and Implications in Inflammation and Infection. Antibiot. 2021; 10(4):425. [PMID] [DOI:10.3390/antibiotics10040425]
15. Paraschos S, Mitakou S, L Skaltsounis A. Chios gum mastic: A review of its biological activities. Curr Med Chem. 2012; 19(14):2292-302. [PMID] [DOI:10.2174/092986712800229014]
16. Özçelik B, Aslan M, Orhan I, Karaoglu T. Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera. Microbiol Res. 2005; 160(2):159-64. [PMID] [DOI:10.1016/j.micres.2004.11.002]
17. Badgujar SB, Patel VV, Bandivdekar AH. Foeniculum vulgare Mill: A review of its botany, phytochemistry, pharmacology, contemporary application, and toxicology. Biomed Res Int. 2014; 2014:842674. [PMID] [DOI:10.1155/2014/842674]
18. Kesharwani A, Polachira SK, Nair R, Agarwal A, Mishra NN, Gupta SK. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement Altern Med. 2017; 17(1):110. [PMID] [DOI:10.1186/s12906-017-1620-8]
19. Li P, Du R, Wang Y, Hou X, Wang L, Zhao X, et al. Identification of chebulinic acid and chebulagic acid as novel influenza viral neuraminidase inhibitors. Front Microbiol. 2020; 11:182. [PMID] [DOI:10.3389/fmicb.2020.00182]
20. Pachi VK, Mikropoulou EV, Gkiouvetidis P, Siafakas K, Argyropoulou A, Angelis A, et al. Traditional uses, phytochemistry and pharmacology of Chios mastic gum (Pistacia lentiscus var. Chia, Anacardiaceae): A review. J Ethnopharmacol. 2020; 254:112485. [PMID] [DOI:10.1016/j.jep.2019.112485]
21. Pazargadi M, Ashktorab T, Alavimajd H, Khosravi S. [Developing an assessment tool for nursing students general clinical performance (Persian)]. Iran J Med Educ. 2013; 12(11):877-87. [Link]
22. Lawshe CH. A quantitative approach to content Validity. Personnal Psychol. 1975; 28(4):563-75. [Link] [DOI:10.1111/j.1744-6570.1975.tb01393.x]
23. Sedighi GH, Maftoon F, Moshrefi M. Knowledge, attitude and use of complementary medicine in Tehran. Payesh. 2004; 3:279-89. [Link]
24. Lotfi MS, Adib-Hajbaghery M, Shahsavarloo ZR, Gandomani HS. The prevalence of traditional and complementary medicine in the general population in Kashan, Iran, 2014. Eur J Integr Med. 2016; 8(5):661-9. [DOI:10.1016/j.eujim.2016.06.006] [DOI:10.1016/j.eujim.2016.06.006]
25. Anbari K, Gholami M. Evaluation of trends in the use of complementary and alternative medicine in health centers in Khorramabad (West of Iran). Glob J Health Sci. 2015; 8(2):72-6. [PMID] [DOI:10.5539/gjhs.v8n2p72]
26. Fesharakinia A, Abedini M. Prevalence of using complementary and alternative medicine in children and its related factors in east Iran. Iran J Pediatr. 2014; 24(1):111-114.
27. Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care (Engl). 2007; 16(2):144-9. [PMID] [DOI:10.1111/j.1365-2354.2006.00722.x]
28. Strouss L, Mackley A, Guillen U, Paul DA, Locke R. Complementary and alternative medicine use in women during pregnancy: Do their healthcare providers know? BMC Complement Altern Med. 2014; 14(1):85. [PMID] [DOI:10.1186/1472-6882-14-85]
29. Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with Diabetes Mellitus. J Integr Med. 2015; 13(5):319-25. [DOI:10.1016/S2095-4964(15)60196-0] [DOI:10.1016/S2095-4964(15)60196-0]
30. Shiri AH, Raiatdoost E, Afkhami H, Ravanshad R, Hosseini SE, Kalani N, et al. The herbal combination of Sugarcane, Black Myrobalan, and mastic as a supplementary treatment for COVID-19: A randomized clinical trial. MedRxiv. 2021. [Link] [DOI:10.1101/2021.04.27.21256221]
31. Sadighi J, Maftoon F, Ziai SA. [Herbal medicine: Knowledge, attitude and practice in Tehran (Persian)]. J Med Plants. 2005; 4(13):60-7. [Link]
32. Hashem-Dabaghian F. [Knowledge of pregnant women about the efficacy and safety of herbal medicine and their practice during pregnancy (Persian)]. J Complement Med. 2012; 2(3):246-56. [Link]
33. Sattari M, Dilmaghanizadeh M, Hamishehkar H, Mashayekhi SO. Self-reported use and attitudes regarding herbal medicine safety during pregnancy in Iran. Jundishapur J Nat Pharm Prod. 2012; 7(2):45-9. [PMID] [DOI:10.5812/jjnpp.3416]
34. Balouchi A, Rahnama M, Hastings-Tolsma M, Shoja MM, Bolaydehyi E. Knowledge, attitude and use of complementary and integrative health strategies: A preliminary survey of Iranian nurses. J Integr Med. 2016; 14(2):121-7. [DOI:10.1016/S2095-4964(16)60245-5] [DOI:10.1016/S2095-4964(16)60245-5]
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.MUQ.REC.1400.005)،

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hashem-Dabaghian F, Nojavan F, Mohammadbeigi A, Aligol M, Shokuhitabar M, Danesh A. Consumption Pattern of Black Myrobalan for Prevention and Treatment of COVID-19 and People’ Attitude Towards it in Qom, Iran: A Cross-Sectional Study. Qom Univ Med Sci J 2022; 16 (1) :52-65
URL: http://journal.muq.ac.ir/article-1-3451-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 1 (April 2022) Back to browse issues page
مجله دانشگاه علوم پزشکی قم Qom University of Medical Sciences Journal
Persian site map - English site map - Created in 0.06 seconds with 30 queries by YEKTAWEB 4533